Dietary supplementation with a specific Lacticaseibacillus paracasei probiotic strain may improve the function of the endothelium and overall heart health in people with metabolic syndrome (MetS), says a new study.
Probi s report for the second quarter 2023 will be published on Tuesday, 18 July at 8.00 a.m. CET.
In conjunction with this, analysts, investors and media are invited to an audiocast telephone.
Press ReleaseJune 2023 Clasado announces synbiotic partnership with Probi AB Clasado Biosciences (‘Clasado’), developer of the multi award-winning prebiotic ingredient Bimuno® GOS, has announced a new partnership with Probi® AB.